Robert D. Kendig

Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance

Pankaj Taneja, Dejan Maglic, Fumitake Kai et al. · Clinical Medicine Insights Oncology · 2010 · 156 citations · Full text

Medicine, Molecular Medicine, Oncology +15

Synthesis and biological evaluation of naphthoquinone analogs as a novel class of proteasome inhibitors

Harshani R. Lawrence, Aslamuzzaman Kazi, Yunting Luo et al. · Bioorganic & Medicinal Chemistry · 2010 · 75 citations

Pharmacy, Medicinal Chemistry, Pharmacology +12

Development of <i>o</i>-Chlorophenyl Substituted Pyrimidines as Exceptionally Potent Aurora Kinase Inhibitors

Harshani R. Lawrence, Mathew P. Martin, Yunting Luo et al. · Journal of Medicinal Chemistry · 2012 · 70 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11

Inappropriate Recruitment and Activity by the Src Homology Region 2 Domain-Containing Phosphatase 1 (SHP1) Is Responsible for Receptor Dominance in the SHIP-Deficient NK Cell

Joseph Wahle, Kim H.T. Paraiso, Robert D. Kendig et al. · The Journal of Immunology · 2007 · 51 citations

Life Sciences, Immunology, Molecular Biology +17

Transgenic and Knockout Mice Models to Reveal the Functions of Tumor Suppressor Genes

Pankaj Taneja, Sinan Zhu, Dejan Maglic et al. · Clinical Medicine Insights Oncology · 2011 · 44 citations · Full text

Medicine, Genetics, Oncology +17